Top compounds associated with response to NRROS


Feature Type Standardized
Nominal ANOVA
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.21 6e-06
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.27 6e-06
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.22 6e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 7e-06
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 7e-06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 7e-06
mRNA PD-0325901 gCSI pan-cancer AAC 0.27 9e-06
mRNA ATRA CTRPv2 pan-cancer AAC 0.2 1e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-05
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.2 2e-05
Download CSV